Sanofi has said it will press ahead with regulatory filings for atopic dermatitis (AD) candidate amlitelimab after reporting positive data in two more phase 3 trials.

With shares down more than 40% since November, the risk-reward for Nektar Therapeutics has shifted ahead of pivotal clinical ...

INDICATIONS ZORYVE cream, 0.05%, is indicated for topical treatment of mild to moderate atopic dermatitis in pediatric patients 2 to 5 years of age. ZORYVE cream, 0.15%, is indicated for topical ...

Our highly trained dermatologists effectively diagnose and treat contact dermatitis in our clinic at University of Utah Health. Contact dermatitis is a skin disorder that occurs when a foreign ...

Sanofi has announced that its amlitelimab has shown positive results in the treatment of patients 12 years and older with atopic dermatitis (AD).

Amgen ends its rocatinlimab partnership, returning control to Kyowa Kirin, citing strategy changes, weaker Phase 3 results ...

Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and ...

Amlitelimab is effective at improving moderate to severe AD across all body regions, including the difficult-to-treat head and neck region.

Dermatitis, a broad term for skin inflammation, encompasses various causes like irritants and allergens. Eczema, however, typically refers to a chronic, recurring form of dermatitis marked by ...

When confronted with chronic eczematous dermatitis, clinicians should try to differentiate between intrinsic (atopic dermatitis [AD]) and extrinsic (allergic or irritant contact dermatitis) causes. AD ...

Contact dermatitis, a common skin reaction, arises from irritants or allergens, causing redness and itching. Two types exist: irritant, from direct damage (80% of cases), and allergic, an immune ...

What is contact dermatitis? Contact dermatitis is a reaction that occurs when something touches your skin and triggers a rash. The rash may appear right away or it could take some time to develop.